| Literature DB >> 34847376 |
Finn Hinrichsen1, Jacob Hamm1, Magdalena Westermann1, Lena Schröder1, Kensuke Shima2, Neha Mishra1, Alesia Walker3, Nina Sommer1, Kenneth Klischies1, Daniela Prasse4, Johannes Zimmermann5, Sina Kaiser1, Dora Bordoni1, Antonella Fazio1, Georgios Marinos5, Georg Laue1, Simon Imm1, Valentina Tremaroli6, Marijana Basic7, Robert Häsler8, Ruth A Schmitz4, Stefan Krautwald9, Andrea Wolf10, Bärbel Stecher11, Philippe Schmitt-Kopplin3, Christoph Kaleta5, Jan Rupp2, Fredrik Bäckhed12, Philip Rosenstiel1, Felix Sommer13.
Abstract
Hexokinases (HK) catalyze the first step of glycolysis limiting its pace. HK2 is highly expressed in gut epithelium, contributes to immune responses, and is upregulated during inflammation. We examined the microbial regulation of HK2 and its impact on inflammation using mice lacking HK2 in intestinal epithelial cells (Hk2ΔIEC). Hk2ΔIEC mice were less susceptible to acute colitis. Analyzing the epithelial transcriptome from Hk2ΔIEC mice during colitis and using HK2-deficient intestinal organoids and Caco-2 cells revealed reduced mitochondrial respiration and epithelial cell death in the absence of HK2. The microbiota strongly regulated HK2 expression and activity. The microbially derived short-chain fatty acid (SCFA) butyrate repressed HK2 expression via histone deacetylase 8 (HDAC8) and reduced mitochondrial respiration in wild-type but not in HK2-deficient Caco-2 cells. Butyrate supplementation protected wild-type but not Hk2ΔIEC mice from colitis. Our findings define a mechanism how butyrate promotes intestinal homeostasis and suggest targeted HK2-inhibition as therapeutic avenue for inflammation.Entities:
Keywords: HK2; butyrate; hexokinase; immunometabolism; inflammation; intestinal epithelial cell; microbiota
Mesh:
Substances:
Year: 2021 PMID: 34847376 DOI: 10.1016/j.cmet.2021.11.004
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287